A retrospective outcome study in the elder patient with locally advanced rectal cancer treated with hypofractionated or conventional preoperative radiotherapy

Florence Guillerme, Jean Emmanuel Kurtz, Jean Baptiste Clavier, Catherine Schumacher, Cecile Brigand, Georges Noël

Abstract


Background: Neoadjuvant chemoradiotherapy is considered the standard approach for T3-4 M0 rectal cancer; however, the optimal dose remains undefined for the elderly. We performed a retrospective analysis to compare conventional (C) and hypofractionated (HF) schedules in elderly patients. We compared survival rates, local control and morbidity.

Methods: From 2000 to 2008, 177 patients older than 65 years with T3-4 M0 rectal cancer received preoperative radiotherapy according to either a conventional protocol (45 to 50.4 Gy in 1.8-2 Gy daily fractions) or a hypofractionated (39 Gy in 3 Gy daily fractions) protocol. Fifty-five patients in the conventional group and none of the patients in the hypofractionated group received concomitant chemotherapy. Both groups were equivalent in terms of their characteristics. The median follow-up was 36 months.

Results: The occurrence of early grade 3-4 radiation toxicity was equivalent between the 2 groups (7%). Surgery was performed in 98% of the patients in the HF group versus 92% in the conventional (p=0.08). The delay between radiotherapy and surgery was 22 days in the HF group versus 45 days in the conventional group (p=0.0021). The downstaging rates were 39% in HF group and 45% in the C group (p=0.53). For lower rectum tumors, the conservative surgery rates were 43% in the HF group and 35% in the C group, (p=0.52). The postoperative death rates at 30 days were equal between the two groups (3%). The 5-year local control rates was 87.3% in group C and 91.7% in group HF (p=0.5). Based on a Kaplan-Meier analysis, the 1-, 3- and 5-year overall survival rates were 88%, 67% and 45%, respectively, in the C group and 84%, 60% and 39%, respectively, in the HF group (p=0.28). In a multivariate analysis, the prognostic factors for overall survival were a Charlson index < 2 (p=0.0034 HR=0.3), pT stage ≤2 (p=0.0042 HR=0.16), pN0 stage (p=0.0072 HR=0.388), and downstaging (p=0.0498 HR=0.651). Radiation schedule and concomitant chemotherapy had no impact.

Conclusion: In this series, the local control rates and the overall survival results are equivalent for patients treated with HP and C radiation schedules. As hypofractionated radiotherapy is more convenient for elderly patients and has equivalent morbidity, additional prospective studies with this population could be of great interest.



Full Text: PDF DOI: 10.5430/jst.v3n2p25

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Journal of Solid Tumors

ISSN 1925-4067(Print)   ISSN 1925-4075(Online)

Copyright © Sciedu Press


To make sure that you can receive messages from us, please add the 'Sciedu.ca' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.